TY - JOUR
T1 - Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension
AU - Soon, Elaine
AU - Holmes, Alan M.
AU - Treacy, Carmen M.
AU - Doughty, Natalie J.
AU - Southgate, Laura
AU - Machado, Rajiv D.
AU - Trembath, Richard C.
AU - Jennings, Simon
AU - Barker, Lucy
AU - Nicklin, Paul
AU - Walker, Christoph
AU - Budd, David C.
AU - Pepke-Zaba, Joanna
AU - Morrell, Nicholas W.
PY - 2010/8/31
Y1 - 2010/8/31
N2 - Background-Inflammation is a feature of pulmonary arterial hypertension (PAH), and increased circulating levels of cytokines are reported in patients with PAH. However, to date, no information exists on the significance of elevated cytokines or their potential as biomarkers. We sought to determine the levels of a range of cytokines in PAH and to examine their impact on survival and relationship to hemodynamic indexes.
Methods and Results-We measured levels of serum cytokines (tumor necrosis factor-alpha, interferon-gamma and interleukin-1 beta, -2, -4, -5, -6, -8, -10, -12p70, and -13) using ELISAs in idiopathic and heritable PAH patients (n=60). Concurrent clinical data included hemodynamics, 6-minute walk distance, and survival time from sampling to death or transplantation. Healthy volunteers served as control subjects (n=21). PAH patients had significantly higher levels of interleukin-1 beta, -2, - 4, - 6, - 8, - 10, and -12p70 and tumor necrosis factor-alpha compared with healthy control subjects. Kaplan-Meier analysis showed that levels of interleukin-6, 8, 10, and 12p70 predicted survival in patients. For example, 5-year survival with interleukin-6 levels of >9 pg/mL was 30% compared with 63% for patients with levels
AB - Background-Inflammation is a feature of pulmonary arterial hypertension (PAH), and increased circulating levels of cytokines are reported in patients with PAH. However, to date, no information exists on the significance of elevated cytokines or their potential as biomarkers. We sought to determine the levels of a range of cytokines in PAH and to examine their impact on survival and relationship to hemodynamic indexes.
Methods and Results-We measured levels of serum cytokines (tumor necrosis factor-alpha, interferon-gamma and interleukin-1 beta, -2, -4, -5, -6, -8, -10, -12p70, and -13) using ELISAs in idiopathic and heritable PAH patients (n=60). Concurrent clinical data included hemodynamics, 6-minute walk distance, and survival time from sampling to death or transplantation. Healthy volunteers served as control subjects (n=21). PAH patients had significantly higher levels of interleukin-1 beta, -2, - 4, - 6, - 8, - 10, and -12p70 and tumor necrosis factor-alpha compared with healthy control subjects. Kaplan-Meier analysis showed that levels of interleukin-6, 8, 10, and 12p70 predicted survival in patients. For example, 5-year survival with interleukin-6 levels of >9 pg/mL was 30% compared with 63% for patients with levels
U2 - 10.1161/CIRCULATIONAHA.109.933762
DO - 10.1161/CIRCULATIONAHA.109.933762
M3 - Article
SN - 1524-4539
VL - 122
SP - 921 - U90
JO - Circulation (Baltimore)
JF - Circulation (Baltimore)
IS - 9
ER -